Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Nobuyuki Kiyosawa"'
Publikováno v:
Nihon Naika Gakkai Zasshi. 103:3067-3070
Autor:
Masao Nakagawa, Hiroyuki Matsuura, Naokata Sumitomo, Nobuyuki Kiyosawa, Masaru Miura, Shozaburoh Doi, Hitoshi Kato, Ayumi Mizukami, Ryuji Fukazawa, In-Sam Park, Masako Fujiwara, Yasukochi Satoshi
Publikováno v:
Pediatric Cardiology and Cardiac Surgery. 30:580-587
Autor:
Tadaki Oomae, Toru Yamamoto, Ryuta Nisikomori, Toshio Osamura, Kenji Kishida, Yasumichi Kuwabara, Kouji Nakajima, Zenrou Kizaki, Tetsuya Yasuno, Hisato Ito, Fumiaki Nakajima, Hiroshi Komatsu, Akitoshi Nakamura, Yuichi Akiyama, Daisuke Fujiwara, Nobuyuki Kiyosawa
Publikováno v:
Pediatrics International. 52:273-278
Background: Respiratory syncytial virus (RSV) infection in infants can develop into a severe condition. Methods: A survey of patients with severe RSV infection in hospitals in Kyoto Prefecture was performed from 2003 to 2007. Patients requiring intub
Autor:
Shinsaku Imashuku, Midori Shima, Kimito Todo, Nobuyuki Kiyosawa, Tadaki Ohmae, Mitsuhiko Sugimoto, Toshio Osamura, Toshihiko Imamura
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 26(8)
Acquired haemophilia A (AHA) is a life-threatening haemorrhagic disorder that occurs with various underlying conditions such as autoimmune disease, drug reactions, lymphoproliferative diseases, solid tumours and pregnancy/postpartum status. However,
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 103(12)
Autor:
Koichi Sakata, Toshiki Itoi, Nobuyuki Kiyosawa, Seiichiro Ozawa, Zenshiro Onouchi, Kenji Hamaoka, Isao Shiraishi
Publikováno v:
Circulation Journal. 69:265-272
Background There are few studies of the therapeutic regimens for the prevention of stenotic transformation of aneurysms in Kawasaki disease (KD). The aim of this study was to assess the prophylactic effect of combined therapy in the acute stage and c
Autor:
Zenshiro Onouchi, Masayoshi Yanagisawa, Hiroshi Matsuda, Mitsuyoshi Nakashima, Tsuneo Hirayama, Nobuyuki Kiyosawa
Publikováno v:
Pediatrics International. 37:40-46
In an initial study, three groups of patients with Kawasaki disease received either aspirin alone or alkylated immunoglobulin G intravenous preparation (IGIV) 200 mg/kg daily x3 days + aspirin, or 400 mg/kg alkylated IGIV daily x3 days + aspirin. In
Publikováno v:
Pediatrics International. 35:186-192
In Japan, the leading cause of death for children over 1 year old is injury, and for children aged 0-14, drowning is the second leading cause of death. The purpose of the present study was to describe the epidemiological factors of drownings and near
Autor:
Hisato Ito, Seiichiro Ozawa, Nobuyuki Kiyosawa, Kenji Hamaoka, Zenshiro Onouchi, Koichi Sakata
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 51(4)
Background: The significance of neutropenia in Kawasaki disease (KD) has not been fully elucidated as yet. Methods: Subjects were retrospectively sampled from two clinical trials. These patients treated with aspirin alone (ASA) and PolyglobinN-Bayel
Autor:
Tatsuo Yokoyama, Tokio Tamura, Yutaka Manabe, Tetsuro Kamiya, Keisuke Shinomiya, Shiro Seto, Kiyoshi Baba, Hiroyuki Nakano, Osamu Hirose, Kunizo Baba, Chuzo Mori, Tadashi Hayashidera, Kunitaka Joho, Nobuyuki Kiyosawa, Kenshi Furusho, Masaharu Kawarano
Publikováno v:
Pediatrics International. 33:799-804
We studied the effect of gamma-globulin (IVGG) and aspirin (ASA) on the development of the coronary artery lesions (CAL) of Kawasaki disease (KD) in three different protocols. Within 29 days of the onset of KD the echocardiographic evidence of CAL ha